SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
541 Prudential says the downgrade is based on current valuation and continued uncerBob L-3/29/2000
540 I would be very curious to know the reasoning behind this: Wednesday March 29,Russian Bear-3/29/2000
539 I hope its good. V1Vector1-3/10/2000
538 short sellers seem to be trying to cover, yesterday was typical. It won't Trey Yon-3/8/2000
537 Very nice strength in the face of yesterday and today. Someone is anticipating jayhawk969-3/8/2000
536 Interesting release from NERX - biz.yahoo.com (disclaimer I own CLTR, not NERX)nigel bates-3/6/2000
535 Forty! How far away did 40 seem 3 months ago? <g> RB Russian Bear-2/16/2000
534 Monday February 14 2:53 PM ET Baffling Rise in Lymphoma Studied By LAURAN NEERBob L-2/15/2000
533 PB, That's a gem of a link, didn't see it among the ASH abstracts. Gobiowa-2/8/2000
532 Thanks, If I loose my day job I will let you know. LOL. V1Vector1-2/7/2000
531 Not sure if an abstract with similar material was presented at ASH, but here itPseudo Biologist-2/7/2000
530 PB, Thanks for the great link! Robinson is a good addition, but <i>blobiowa-2/7/2000
529 V1, <i>I think you meant Bex should win</i> Oh. Yeah. Just didnbiowa-2/7/2000
528 biowa, geocities.com Just links to the IBM (nice but incomplete, unless one pPseudo Biologist-2/5/2000
527 <<moment when Genentech walked away from Zev it was dead for me and no coVector1-2/5/2000
526 <<Net: If efficacy is the primary issue, IMHO Rit should win, otherwise iMiljenko Zuanic-2/5/2000
525 Biowa, You had me nodding my head in agreement until the last sentence. <<Vector1-2/5/2000
524 Miljenko, <i>when Genentech walked away from Zev it was dead for me and biowa-2/5/2000
523 Folks, "PB note" re. dosimetry was a reference to better supported coPseudo Biologist-2/5/2000
522 Biowa, I didn't read any of this patents (only briefly claims), so even ifMiljenko Zuanic-2/4/2000
521 Miljenko, Want to echo V1 and your sentiments - it's the molecule that matbiowa-2/4/2000
520 V1, In this case I agree 200%. Nonetheless, if regular investors do not undeMiljenko Zuanic-2/4/2000
519 Miljenko, While I am pleased with CLTR's price appreciation, I am concernedVector1-2/3/2000
518 Biowa, No, I didn't said that you or anyone else proclaimed victory in regMiljenko Zuanic-2/3/2000
517 PB, <i>Time to add a patent section to the shrine?</i> Yes, Yes, biowa-2/3/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):